Highlights from Third Bridge Forum's MedTech Week

  • Public Equity
  • Healthcare
  • North America

Third Bridge Forum delved into some of the most innovative areas of structural heart devices in a series of Interviews in October 2022. During the hour-long Interviews, Forum unpacked novel products such as Abbott Laboratories’ Amplatzer Amulet offering to treat left atrial appendage closure (LAAC), as well as Edwards Lifesciences’ Pascal for patients with degenerative mitral regurgitation, which is expected to come to market in late 2022. Here are some of the key insights gleaned from the five Interviews.

Read More

Submit your email address for full access to our Research content.